{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:34:23Z","timestamp":1785598463304,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lipid metabolism abnormalities are an emerging risk factor for cardiovascular diseases. Due to the nature of the condition and their unhealthy lifestyles, patients with mental illnesses have a doubled risk of morbidity and mortality from dyslipidemia compared to the general population. To our knowledge the magnitude of dyslipidemia in patients with mental illnesses in the eastern Ethiopia has not been reported in the literature to date. Therefore, the aim of the study was to assess and compare the magnitude of dyslipidemia and its predictors among patients with severe mental illnesses and non-mentally ill control patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Nighty six subjects with serious psychiatric disorders and nighty six matched non-psychiatric control subjects who had no history of psychiatric illness were underwent a lipid profile test in Dire Dawa referral hospital, Ethiopia. The mentally ill clients were 18 years of age and older with schizophrenia, major depression, and bipolar disorders. Exposed study subjects were matched to control by age and sex. The data were cleaned and analyzed using SPSS software. A binary logistic regression model was used to determine the factors related to the magnitude of dyslipidemia. Both the crude odds ratio and the adjusted odds ratio with a 95% confidence interval were estimated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The magnitude of dyslipidemia among mentally ill patients was significantly higher (63.54%) compared to non-exposed controls (31.9%) in the subjects studied. In multiple logistic regression, urban dwellers were six times (AOR\u2009=\u20096.14, 95% CI: 1.2, 16) more likely at risk of developing dyslipidemia compared to rural participants. Similarly, physically inactive participants were nearly two-times (AOR\u2009=\u20091.8, 95% CI: 1.1, 12.9) more likely to develop dyslipidemia compared to physically active study participants. Moreover, study participants who had raised body mass index were 2.1 times (AOR\u2009=\u20092.1, 95% CI: 1.17, 15.3) more likely having dyslipidemia than their counterparts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study revealed that the prevalence of dyslipidemia is higher among mentally ill patients compared to non-mentally ill control study participants. Place of residence, physical inactivity, and raised BMI were significantly associated with dyslipidemia. Therefore, intensive screening of patients for dyslipidemia and its components is necessary during follow-up.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03327-3","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T18:01:53Z","timestamp":1686679313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, Ethiopia: neglected public health concern"],"prefix":"10.1186","volume":"23","author":[{"given":"Dilnessa","family":"Fentie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shegaye","family":"Yibabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"3327_CR1","unstructured":"Et.al ana T. Pathophysiology of Dyslipidemia in Modern Medicine and its correlation. J Sci Hea lthcare Res. 2019;4(1)."},{"issue":"9","key":"3327_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.5551\/jat.RV17023","volume":"25","author":"T Hirano","year":"2018","unstructured":"Hirano T. Pathophysiology of dyslipidemia. J Atheroscler Thromb. 2018;25(9):771\u201382.","journal-title":"J Atheroscler Thromb"},{"issue":"2","key":"3327_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4103\/0253-7176.130982","volume":"36","author":"PL Prasuna","year":"2014","unstructured":"Prasuna PL, Sagar KJV, Sudhakar TP, Rao GP. A placebo controlled trial on add-on modafinil on the anti-psychotic treatment emergent hyperglycemia and hyperlipidemia. Indian J Psychol Med. 2014;36(2):158\u201363.","journal-title":"Indian J Psychol Med"},{"issue":"12","key":"3327_CR4","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1017\/S0033291715000562","volume":"45","author":"P Gardner-Sood","year":"2015","unstructured":"Gardner-Sood P, Lally J, Smith S, Atakan Z, Ismail K, Greenwood KE, et al. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychol Med. 2015;45(12):2619\u201329.","journal-title":"Psychol Med"},{"issue":"1","key":"3327_CR5","first-page":"1","volume":"36","author":"O Abosi","year":"2018","unstructured":"Abosi O, Lopes S, Schmitz S, Fiedorowicz JG. Cardiometabolic effects of psychotropic medications. Horm Mol Biol Clin Investig. 2018;36(1):1\u201315.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"2","key":"3327_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.comppsych.2013.09.009","volume":"55","author":"H Carliner","year":"2014","unstructured":"Carliner H, Collins PY, Cabassa LJ, McNallen A, Joestl SS, Lewis-Fern\u00e1ndez R. Prevalence of cardiovascular risk factors among racial and ethnic minorities with schizophrenia spectrum and bipolar disorders: a critical literature review. Compr Psychiatry. 2014;55(2):233\u201347.","journal-title":"Compr Psychiatry"},{"issue":"12","key":"3327_CR7","first-page":"WC04","volume":"8","author":"S John","year":"2014","unstructured":"John S, Dharwadkar K, Motagi MV. Study on association between lipid profile values and psychiatric disorders. J Clin Diagnostic Res. 2014;8(12):WC04\u20136.","journal-title":"J Clin Diagnostic Res"},{"issue":"1","key":"3327_CR8","first-page":"1","volume":"36","author":"O Abosi","year":"2019","unstructured":"Abosi O, Lopes S, Schmitz S, Fiedorowicz G, City I, City I, et al. Cardiometabolic Effects of psychotropic medications Oluchi. Horm Mol Biol Clin Investig. 2019;36(1):1\u201327.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"10","key":"3327_CR9","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1176\/ajp.2006.163.10.1821","volume":"163","author":"M Olfson","year":"2006","unstructured":"Olfson M. Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry. 2006;163(10):1821.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3327_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.9758\/cpn.2013.11.2.80","volume":"11","author":"YK Ko","year":"2013","unstructured":"Ko YK, Soh MA, Kang SH, Lee J, Il. The prevalence of metabolic syndrome in schizophrenic patients using antipsychotics. Clin Psychopharmacol Neurosci. 2013;11(2):80\u20138.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"5","key":"3327_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1017\/S1461145708008468","volume":"11","author":"AO Vik-Mo","year":"2008","unstructured":"Vik-Mo AO, Birkenaes AB, Fern\u00f8 J, Jonsdottir H, Andreassen OA, Steen VM. Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients. Int J Neuropsychopharmacol. 2008;11(5):679\u201384.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3327_CR12","doi-asserted-by":"publisher","unstructured":"Yang F, Ma Q, Ma B, Jing W, Liu J, Guo M et al. Dyslipidemia prevalence and trends among adult mental disorder inpatients in Beijing, 2005\u20132018: A longitudinal observational study. Asian J Psychiatr [Internet]. 2021;57:102583. Available from: https:\/\/doi.org\/10.1016\/j.ajp.2021.102583.","DOI":"10.1016\/j.ajp.2021.102583"},{"issue":"1","key":"3327_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2174\/1874944501811010416","volume":"11","author":"YT Al-Hassan","year":"2018","unstructured":"Al-Hassan YT, Fabella EL, Estrella E, Aatif M. Prevalence and determinants of Dyslipidemia: data from a Saudi University Clinic. Open Public Health J. 2018;11(1):416\u201324.","journal-title":"Open Public Health J"},{"issue":"4","key":"3327_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/2047487312465525","volume":"21","author":"AA Gehani","year":"2014","unstructured":"Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W, Hasani MRM, Yusufali AH, et al. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. Eur J Prev Cardiol. 2014;21(4):400\u201310.","journal-title":"Eur J Prev Cardiol"},{"issue":"9","key":"3327_CR15","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1016\/S2214-109X(18)30275-4","volume":"6","author":"JJ Noubiap","year":"2018","unstructured":"Noubiap JJ, Bigna JJ, Nansseu JR, Nyaga UF, Balti EV, Echouffo-Tcheugui JB, et al. Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis. Lancet Glob Heal. 2018;6(9):e998\u20131007.","journal-title":"Lancet Glob Heal"},{"key":"3327_CR16","doi-asserted-by":"crossref","unstructured":"Hirigo AT, Teshome T, Abera Gitore W, Worku E. Prevalence and Associated factors of Dyslipidemia among Psychiatric patients on antipsychotic treatment at Hawassa University Comprehensive Specialized Hospital. Nutr Metab Insights. 2021;14.","DOI":"10.1177\/11786388211016842"},{"key":"3327_CR17","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.2147\/DMSO.S283171","volume":"13","author":"K Haile","year":"2020","unstructured":"Haile K, Timerga A. Dyslipidemia and its associated risk factors among adult type-2 diabetic patients at jimma university medical center, Jimma, Southwest Ethiopia. Diabetes Metab Syndr Obes Targets Ther. 2020;13:4589\u201397.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"3327_CR18","doi-asserted-by":"publisher","unstructured":"Gebreegziabiher G, Belachew T, Mehari K, Tamiru D. Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia. PLoS One [Internet]. 2021;16(2 February):1\u201318. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0243103.","DOI":"10.1371\/journal.pone.0243103"},{"issue":"6","key":"3327_CR19","first-page":"1267","volume":"31","author":"WM Kebede","year":"2021","unstructured":"Kebede WM, Gizachew KD, Mulu GB. Prevalence and risk factors of Dyslipidemia among type 2 diabetes patients at a Referral Hospital, North Eastern Ethiopia. Ethiop J Health Sci. 2021;31(6):1267\u201376.","journal-title":"Ethiop J Health Sci"},{"issue":"3","key":"3327_CR20","first-page":"1","volume":"150","author":"\u00cbJ Flynn","year":"2015","unstructured":"Flynn \u00cbJ, Waldo B. Gauging the treatment gap in dyslipidemia: findings from the 2009\u20132014 National Health and Nutrition Examination Survey. Am Heart J. 2015;150(3):1\u20138.","journal-title":"Am Heart J"},{"key":"3327_CR21","doi-asserted-by":"publisher","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol [Internet]. 2021;18(10):689\u2013700. Available from: https:\/\/doi.org\/10.1038\/s41569-021-00541-4.","DOI":"10.1038\/s41569-021-00541-4"},{"issue":"5","key":"3327_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.dsx.2018.04.037","volume":"12","author":"A Sintayehu","year":"2018","unstructured":"Sintayehu A, Bekele S, Tolessa D, Cheneke W. Met and associated factors among psychiatric patients in Jimma University Specialized Hospital, South West Ethiopia. Diabetes Metab Syndr Clin Res Rev. 2018;12(5):753\u201360.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"3327_CR23","doi-asserted-by":"crossref","unstructured":"Gelaye B, Girma B, Lemma S, Berhane Y. Prevalence of metabolic syndrome among working adults in Ethiopia Prevalence of metabolic syndrome among working adults in Ethiopia. Int J Hypertens. 2011;(10).","DOI":"10.4061\/2011\/193719"},{"issue":"2","key":"3327_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1590\/S2317-17822013000200017","volume":"25","author":"DE Battle","year":"2013","unstructured":"Battle DE. Diagnostic and statistical Manual of Mental Disorders (DSM) published by the american Psychiatric Association (APA)-DSM-5. Codas. 2013;25(2):190\u20131.","journal-title":"Codas"},{"issue":"12 SUPPL","key":"3327_CR25","first-page":"301","volume":"8","author":"RL Talbert","year":"2002","unstructured":"Talbert RL. New therapeutic options in the national cholesterol Education Program Adult Treatment Panel III. Am J Manag Care. 2002;8(12 SUPPL):301\u20137.","journal-title":"Am J Manag Care"},{"issue":"1","key":"3327_CR26","first-page":"1","volume":"32","author":"A Mariam","year":"2014","unstructured":"Misganaw Dr, Mariam A, Ali DH, Araya A. Epidemiology of major non-communicable diseases in Ethiopia: a systematic review. J Heal Popul Nutr. 2014;32(1):1\u201313.","journal-title":"J Heal Popul Nutr"},{"issue":"1","key":"3327_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx","volume":"20","author":"BWJH Penninx","year":"2018","unstructured":"Penninx BWJH, Lange SMM. Cardio metabolic disorders in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci. 2018;20(1):63\u201373.","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"3327_CR28","doi-asserted-by":"publisher","first-page":"9562","DOI":"10.4238\/2015.August.14.19","volume":"14","author":"MW Si","year":"2015","unstructured":"Si MW, Yang MK, Fu XD. Effect of hypothalamic-pituitary-adrenal axis alterations on glucose and lipid metabolism in diabetics. Genet Mol Res. 2015;14(3):9562\u201370.","journal-title":"Genet Mol Res"},{"issue":"1","key":"3327_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijcard.2014.03.163","volume":"174","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Kim Y, Cho Y, Jun B, Oh KW. Trends in the prevalence of major cardiovascular disease risk factors among korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998\u20132012. Int J Cardiol. 2014;174(1):64\u201372.","journal-title":"Int J Cardiol"},{"issue":"11","key":"3327_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.annepidem.2014.08.001","volume":"24","author":"M Basulaiman","year":"2014","unstructured":"Basulaiman M, El Bcheraoui C, Tuffaha M, Robinson M, Daoud F, Jaber S, et al. Hypercholesterolemia and its associated risk factors-Kingdom of Saudi Arabia, 2013. Ann Epidemiol. 2014;24(11):801\u20138.","journal-title":"Ann Epidemiol"},{"key":"3327_CR31","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.metop.2021.100108","volume":"11","author":"ZD Kifle","year":"2021","unstructured":"Kifle ZD, Alehegn AA, Adugna M, Bayleyegn B. Prevalence and predictors of dyslipidemia among hypertensive patients in Lumame Primary Hospital, Amhara, Ethiopia: a cross-sectional study. Metab Open. 2021;11:100108.","journal-title":"Metab Open"},{"key":"3327_CR32","doi-asserted-by":"crossref","unstructured":"Kemal A, Ahmed M, Sinaga Teshome M, Abate KH. Central Obesity and Associated Factors among Adult Patients on Antiretroviral Therapy (ART) in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia. J Obes. 2021; 2021:221\u201331.","DOI":"10.2147\/HIV.S252391"},{"key":"3327_CR33","unstructured":"Kolovou G, et al. Pathophysiology of Dyslipidemia in the metabolic syndrome. Postgrad Med journa; 2014."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03327-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03327-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03327-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T18:02:32Z","timestamp":1686679352000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03327-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3327"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03327-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was done in accordance with the Helsinki declaration of studies on human study participants. Ethical clearance was obtained from the Institutional Review Board (IRB) at Dire Dawa University (protocol no.300\/2021). All study participants signed an informed consent form before enrollment in the study. When study participants were illiterate, the data collectors read to them about the procedure and the consent form. Following that, informed consent with inked fingerprints was obtained from each study participant to engage in the study willingly. All participants who had lipid disorders were linked to service providers for further evaluation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared, no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}